ArticleMolecular & cellular proteomics : MCP2016

Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.

Graziella E Ronsein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.